跳至主要内容
临床试验/CTRI/2026/02/102970
CTRI/2026/02/102970尚未招募2/3 期

Randomized controlled clinical trial to evaluate the efficacy of laghu manjisthadi kwatha in the management of vata rakta (gout)

Dr Komal Manoj Rathi1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年2月16日最近更新:
适应症
相关药物

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1.Sandhishool (Pain)

研究概览

简要总结

Vatarakta is described under vatavyadhi nidan adhyaya by achrya shushrut and acharya vagbhata and acharya charaka has given separate chapter for this disease.It is madhyam marg gat vyadhi because it mainly affects sandhis.

Vatarakta is named on the basis of Vata dosha and Rakta dhatu which have their own independent derivations and are the main samprapti ghataka involved in the vatarakta. It is considered that the life of all living beings depends on Rakta. By excessive intake of hot,sour,irritant,alkaline food items,exposure to too much heat Rakta dhatu gets vitiated and if the same individuals with vitiated Rakta dhatu starts taking Vata prakopak ahara and vihara,it will cause vitiation of vata dosha.

It can be correlated with Gout due to similaritis in their symptoms.These days,due to rapid modernization ,consumption of half fried food or baked food causes impairement in digestion and metabolism making human being prone to many life threating ailments like stroke or functional impairement like in joint disorders. Among all these ailments vatarakta is a common presentation with symptoms like severe pain, inflammation, burning sensation and tenderness in the aggected joints.Gout is the true crystal deposition disease and it is a pathological reaction of the joint or particular tissue to the presence of monosodium urate monohydrate crystals.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • •Patients having sign and symptoms of purva rupa(early symptoms) and rupa (symptoms) of Vatarakta.
  • •Symptoms of Vatarakta a.
  • •Sandhishool (Pain) b.
  • •Sandhidaha (Burning sensation) c.
  • •Sandhishoth (Swelling) d.
  • •Sparshasahtva (Tenderness) e.
  • •Sandhistabdhata (Stiffness)
  • •Patients showing sign and symptoms of Vatarakta less than 1 year.
  • •Patients having uric acid level more than 7mg/dl in male.
  • •more than 6mg/dl in female.

排除标准

  • •Patients below 20 and above 70 years of age.
  • •Long standing chronic cases of Vatarakta with Updrava of Vatarakta.
  • •Patients having Inflammatory joint disorder such as osteoarthritis,tubercular arthritis .
  • •Patients with auto immune joint disorder except RA.
  • •Patients suffering from carcinoma.
  • •Patients having HIV and other immunocomprisive disease.
  • •Pregnant and lactating women.

结局指标

主要结局

1.Sandhishool (Pain)

时间窗: 21 days

2.Sandhidaha (Burning sensation)

时间窗: 21 days

3.Sandhishoth (Swelling)

时间窗: 21 days

will be reduced

时间窗: 21 days

次要结局

  • 1.Sparshashatva (Tenderness)(2.Sandhistabdhata (stiffness))

研究者

发起方
Dr Komal Manoj Rathi
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Komal Manoj Rathi

C.S.M.S.S Ayurved mahavidyalaya and rugnalaya

研究点 (1)

Loading locations...

相似试验